Cencora INC CENCORA INC ORD SHS
Cencora INC CENCORA INC ORD SHS/ US03073E1055 /
0HF3
|
18/11/2024 19:06:31
|
Chg.
-
|
Volume |
Bid06:00:08 |
Demandez à06:00:08 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
243.20USD
|
-
|
1,931
Chiffrre d'affaires: 466,807.31 |
-Bid taille: - |
-Ask la taille: - |
47.86 Mrd.USD |
0.80% |
28.18 |
Description de l'entreprise
Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
Conseil d'administration & Conseil de surveillance
| PDG |
| Steven H. Collis |
| Conseil d'administration |
| James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas |
| Conseil de surveillance |
| Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D. |
Données de l'entreprise
| Nom: |
Cencora Inc |
| Adresse: |
1 West First Avenue,Conshohocken, PA 19428-1800, USA |
| Téléphone: |
+1-610-727-7000 |
| Fax: |
+1-800-640-5221 |
| Courriel: |
InvestorRelations@cencora.com
|
| Internet: |
https://www.cencora.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
30/09 |
| Flotte libre: |
55.10% |
| IPO date: |
04/04/1995 |
Relations avec les investisseurs
| Nom: |
Bennett Murphy |
| Téléphone IR: |
+1-610-727-3693 |
| IR-Fax: |
- |
| E-mail IR: |
bennett.murphy@cencora.com
|
